{"parse":{"title":"Uppsala Monitoring Centre","pageid":6750473,"revid":795235711,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Uppsala_Monitoring_Centre_facade_logo.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Uppsala_Monitoring_Centre_facade_logo.jpg/220px-Uppsala_Monitoring_Centre_facade_logo.jpg\" width=\"220\" height=\"147\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Uppsala_Monitoring_Centre_facade_logo.jpg/330px-Uppsala_Monitoring_Centre_facade_logo.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Uppsala_Monitoring_Centre_facade_logo.jpg/440px-Uppsala_Monitoring_Centre_facade_logo.jpg 2x\" data-file-width=\"3000\" data-file-height=\"2000\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Uppsala_Monitoring_Centre_facade_logo.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Uppsala Monitoring Centre's logo as seen on the facade of its office building in Uppsala, Sweden.</div></div></div>\n<p><b>Uppsala Monitoring Centre</b> (<b>UMC</b>), located in <a href=\"/wiki/Uppsala\" title=\"Uppsala\">Uppsala</a>, <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a>, is the field name for the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> <a href=\"/wiki/WHO_Collaborating_Centres\" title=\"WHO Collaborating Centres\">Collaborating Centre</a> for International Drug Monitoring. UMC works by collecting, assessing and communicating information from member countries' national <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a> centres in regard to the benefits, harm, effectiveness and risks of drugs.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Background\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Background</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#WHO_Programme_key_dates\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">WHO Programme key dates</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Background\">Background</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Uppsala_Monitoring_Centre&amp;action=edit&amp;section=1\" title=\"Edit section: Background\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Since 1978, responsibility for managing the WHO Programme for International Drug Monitoring has been carried by UMC. In the early years the staff consisted of just three pharmacists based at the Swedish <a href=\"/wiki/Medical_Products_Agency\" class=\"mw-redirect\" title=\"Medical Products Agency\">Medical Products Agency</a> (L\u00e4kemedelsverket); currently over 100 staff work in central Uppsala. The founding chairman and acting Director was Professor \u00c5ke Liljestrand. From 1990 to 2009 the Director was Professor Ralph Edwards.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> Since September 2009 Dr. Marie Lindquist is the Director.  The Chief Medical Officer is Dr. Pia Caduff and the Head of Research is Dr. Niklas Nor\u00e9n.\n</p><p>The work of the UMC is:\n</p>\n<ul><li>To co-ordinate the WHO Programme for International Drug Monitoring and its more than 100 member countries.</li>\n<li>To collect, assess and communicate information from member countries about the benefits, harms and risks of drugs and other substances used in medicine to improve patient therapy and public health worldwide</li>\n<li>To collaborate with member countries in the development and practice of the science of pharmacovigilance.</li></ul>\n<p>The main focus and source of data in <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a> are reports of ICSRs (individual case safety reports) from healthcare providers and patients in member countries of the WHO Programme. A WHO global individual case safety report database (<a href=\"/wiki/VigiBase\" title=\"VigiBase\">VigiBase</a>) is maintained and developed on behalf of the WHO by UMC.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> UMC develops and provides several tools and classifications for use by organisations involved in drug safety, including the <a href=\"/wiki/WHO_Drug_Dictionary\" title=\"WHO Drug Dictionary\">WHO Drug Dictionary</a>, <a href=\"/wiki/WHOART\" title=\"WHOART\">WHOART</a> (adverse reaction terminology)<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> \u2013 with a bridge to the <a href=\"/wiki/MedDRA\" title=\"MedDRA\">MedDRA</a> terminology, tools for searching in the database, and a program for case report management, VigiFlow.<sup id=\"cite_ref-GuptaEd_5-0\" class=\"reference\"><a href=\"#cite_note-GuptaEd-5\">&#91;5&#93;</a></sup>\n</p><p>UMC's research covers mainly three areas: data-driven discovery (especially statistical techniques), dis-proportionality analyses, interaction detection, patterns and duplicate case detection), safety surveillance and signaling (among which drug dependence and pediatric use) and benefit\u2014risk analysis.<sup id=\"cite_ref-Coberttelerx_6-0\" class=\"reference\"><a href=\"#cite_note-Coberttelerx-6\">&#91;6&#93;</a></sup>\n</p><p>The centre has been active in presenting research in the medical literature which has included some seminal works in the field.<sup id=\"cite_ref-Coberttelerx_6-1\" class=\"reference\"><a href=\"#cite_note-Coberttelerx-6\">&#91;6&#93;</a></sup> The Uppsala centre has also published books in the field of drugs safety including a regular newsletter.<sup id=\"cite_ref-GuptaEd_5-1\" class=\"reference\"><a href=\"#cite_note-GuptaEd-5\">&#91;5&#93;</a></sup> In 2010 the 2nd edition of a crisis management guide was published, entitled 'Expecting the Worst'.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>UMC's role in drug safety has not been without controversy for both medicines agencies and pharmaceutical companies, despite an open approach willing to engage with many parties in the pharmaceutical world. They are closely involved in outreach to developing countries and other areas where pharmacovigilance is not yet handled.<sup id=\"cite_ref-Coberttelerx_6-2\" class=\"reference\"><a href=\"#cite_note-Coberttelerx-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"WHO_Programme_key_dates\">WHO Programme key dates</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Uppsala_Monitoring_Centre&amp;action=edit&amp;section=2\" title=\"Edit section: WHO Programme key dates\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>1968 WHO Programme established.  International ADR terminology and drug dictionary</li>\n<li>1969 Definition of ADR</li>\n<li>1978 Operations transferred to the UMC; setting-up of relational ADR database.  Regular WHO Programme member meetings</li>\n<li>1981 Computerised version of <a href=\"/wiki/WHO_Drug_Dictionary\" title=\"WHO Drug Dictionary\">WHO Drug Dictionary</a> available to all</li>\n<li>1982 ATC classification coding of all medicinal products</li>\n<li>1985 International expert review panel created</li>\n<li>1991 On-line WHO database search programme available to national centres</li>\n<li>1991 Definitions of adverse event, side effect and causality assessment terms</li>\n<li>1993 Windows-based client server program for online database searches</li>\n<li>1993 Regular training and educational activities</li>\n<li>1994 Methodology for use of denominator data for calculation of ADR reporting rates</li>\n<li>1997 Knowledge-detection tool for automated signal detection (<a href=\"/wiki/Bcpnn\" title=\"Bcpnn\">BCPNN</a>)</li>\n<li>1997 Promotion of communication as a necessary discipline in pharmacovigilance&#160;: the 'Erice Declaration'</li>\n<li>1998 Internet discussion group for national centres</li>\n<li>2001 Start of VigiBase Online project (now VigiFlow)</li>\n<li>2002 New database system (VigiBase)</li>\n<li>2004 Pattern recognition using the <a href=\"/wiki/Bcpnn\" title=\"Bcpnn\">BCPNN</a> on health databases to find safety information.</li>\n<li>2005 Launch of expanded WHO Drug Dictionary with additional data fields; agreement with IMS Health to increase information in the dictionary</li>\n<li>2010 100th country joins the WHO Programme for International Drug Monitoring</li>\n<li>2012 Over 7 million adverse reaction reports in VigiBase, the WHO ICSR database</li>\n<li>2015 Over 12 million adverse drug reaction reports in VigiBase, the WHO ICSR database<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Uppsala_Monitoring_Centre&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/International_Conference_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use\" class=\"mw-redirect\" title=\"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use\">International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use</a> (ICH)</li>\n<li><a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">Council for International Organizations of Medical Sciences</a> (CIOMS)</li>\n<li><a href=\"/wiki/International_Society_of_Pharmacovigilance\" title=\"International Society of Pharmacovigilance\">International Society of Pharmacovigilance</a></li>\n<li><a href=\"/wiki/Society_of_Pharmacovigilance,_India\" title=\"Society of Pharmacovigilance, India\">Society of Pharmacovigilance, India</a></li>\n<li><a href=\"/wiki/EudraVigilance\" title=\"EudraVigilance\">EudraVigilance</a> (EEA)</li>\n<li><a href=\"/wiki/Yellow_Card_Scheme\" title=\"Yellow Card Scheme\">Yellow Card Scheme</a> (UK)</li>\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a></li>\n<li><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a></li>\n<li><a href=\"/wiki/MedDRA\" title=\"MedDRA\">MedDRA</a></li>\n<li><a href=\"/wiki/WHOART\" title=\"WHOART\">WHOART</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Uppsala_Monitoring_Centre&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><i>Drug Benefits and Risks \u2013 International Textbook of Clinical Pharmacology (2nd edition)</i>. Van Boxtel C, Santoso B and Edwards IR, eds. IOS Press, Amsterdam, 2008.</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\">Spross \u00c5. Uppsala leder forskning om biverkningar. <i>Uppsala Nya Tidning</i>, 28 December 2008.</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\">Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. <i>Drug Information Journal</i>, 2008, 42:409\u2013419.</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/WHO/\">US National Library of Medicine, 2010 entry for UMC</a>, retrieved 28 January 2014</span>\n</li>\n<li id=\"cite_note-GuptaEd-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GuptaEd_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GuptaEd_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><i>Textbook of Pharmacovigilance (Chapter 11).</i> Ed: SK Gupta. Jaypee Brothers Medical Publishers, New Delhi, 2011.</span>\n</li>\n<li id=\"cite_note-Coberttelerx-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Coberttelerx_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Coberttelerx_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Coberttelerx_6-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.telerx.com/blog/the-uppsala-monitoring-centre-umc/\">Telerx website; description and critique of the Uppsala Monitoring Centre</a>, retrieved 28 January 2014.</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Clark D. Review: Expecting the Worst \u2013 a publication from the Uppsala Monitoring Centre. <i>Drug Safety</i> 2010; 33(12):1135\u201336.</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.who-umc.org/media/1237/uppsalareports-may-2016.pdf#page=14\">\"Uppsala Reports 72\"</a> <span style=\"font-size:85%;\">(PDF)</span>. 1 May 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">10 August</span> 2016</span>  &#8211; via Uppsala Monitoring Centre.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Uppsala+Reports+72&amp;rft.date=2016-05-01&amp;rft_id=https%3A%2F%2Fwww.who-umc.org%2Fmedia%2F1237%2Fuppsalareports-may-2016.pdf%23page%3D14&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AUppsala+Monitoring+Centre\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Uppsala_Monitoring_Centre&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external autonumber\" href=\"https://www.who-umc.org\">[1]</a>, Uppsala Monitoring Centre home</li>\n<li><a rel=\"nofollow\" class=\"external autonumber\" href=\"https://www.who-umc.org/safer-use-of-medicines/uppsala-reports\">[2]</a>, Uppsala Reports is UMC's quarterly magazine for everyone concerned with the issues of pharmacovigilance.</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1256\nCached time: 20180908174354\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.068 seconds\nReal time usage: 0.088 seconds\nPreprocessor visited node count: 231/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 1743/2097152 bytes\nTemplate argument size: 89/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4300/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.019/10.000 seconds\nLua memory usage: 1.34 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   54.885      1 Template:Reflist\n100.00%   54.885      1 -total\n 75.51%   41.442      1 Template:Cite_news\n  3.52%    1.931      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:6750473-0!canonical and timestamp 20180908174354 and revision id 795235711\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"World_Health_Organization"},{"sortkey":"","*":"Pharmacological_societies"},{"sortkey":"","*":"Pharmaceuticals_policy"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"Organizations_established_in_1978"},{"sortkey":"","*":"WHO_Collaborating_Centres"}],"links":[{"ns":0,"exists":"","*":"Bcpnn"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"EudraVigilance"},{"ns":0,"exists":"","*":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"ns":0,"exists":"","*":"International Society of Pharmacovigilance"},{"ns":0,"exists":"","*":"MedDRA"},{"ns":0,"exists":"","*":"Medical Products Agency"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Society of Pharmacovigilance, India"},{"ns":0,"exists":"","*":"Sweden"},{"ns":0,"exists":"","*":"Uppsala"},{"ns":0,"exists":"","*":"VigiBase"},{"ns":0,"exists":"","*":"WHOART"},{"ns":0,"exists":"","*":"WHO Collaborating Centres"},{"ns":0,"exists":"","*":"WHO Drug Dictionary"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"Yellow Card Scheme"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Uppsala_Monitoring_Centre_facade_logo.jpg"],"externallinks":["https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/WHO/","http://www.telerx.com/blog/the-uppsala-monitoring-centre-umc/","https://www.who-umc.org/media/1237/uppsalareports-may-2016.pdf#page=14","https://www.who-umc.org","https://www.who-umc.org/safer-use-of-medicines/uppsala-reports"],"sections":[{"toclevel":1,"level":"2","line":"Background","number":"1","index":"1","fromtitle":"Uppsala_Monitoring_Centre","byteoffset":759,"anchor":"Background"},{"toclevel":1,"level":"2","line":"WHO Programme key dates","number":"2","index":"2","fromtitle":"Uppsala_Monitoring_Centre","byteoffset":4365,"anchor":"WHO_Programme_key_dates"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"Uppsala_Monitoring_Centre","byteoffset":6193,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Uppsala_Monitoring_Centre","byteoffset":6629,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Uppsala_Monitoring_Centre","byteoffset":6657,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Uppsala Monitoring Centre","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q7899169"}]}}